Advertisement

Topics

Vernalis stopped cold: US FDA rejects cough medicine NDA

06:33 EDT 10 Aug 2017 | in-PharmaTechnologis

The US FDA has rejected Vernalis’ new drug application for its investigative cough and cold treatment CCP-08, which is the second time the firm has failed to win approval for a product this year.  

Original Article: Vernalis stopped cold: US FDA rejects cough medicine NDA

NEXT ARTICLE

More From BioPortfolio on "Vernalis stopped cold: US FDA rejects cough medicine NDA"

Quick Search
Advertisement
 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...